Secondary hypertension, unspecified
ICD-10 I15.9 is a billable code used to indicate a diagnosis of secondary hypertension, unspecified.
Secondary hypertension, unspecified (I15.9) refers to high blood pressure that is a consequence of another underlying condition. Common causes include renal disease, endocrine disorders, and certain medications. Clinically, patients may present with elevated blood pressure readings, headaches, or asymptomatic findings during routine examinations. The anatomy involved primarily includes the cardiovascular system, particularly the heart and blood vessels, which are affected by the increased pressure. Disease progression can lead to complications such as heart failure, stroke, and renal impairment if not properly managed. Diagnostic considerations include a thorough patient history, physical examination, and targeted laboratory tests to identify the underlying cause of hypertension. It is essential to differentiate secondary hypertension from primary hypertension (essential hypertension), as treatment strategies may differ significantly based on the underlying etiology.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I15.9 encompasses hypertension caused by various conditions such as chronic kidney disease, Cushing's syndrome, hyperaldosteronism, and certain medications. It is crucial to identify the specific underlying condition for accurate diagnosis and treatment.
I15.9 should be used when the hypertension is known to be secondary to another condition but the specific cause is not documented. If a specific cause is identified, the appropriate code from I15.0-I15.8 should be used instead.
Documentation should include a comprehensive patient history, results from diagnostic tests that indicate secondary causes, and any relevant treatment plans. Clear notes on the patient's response to treatment and follow-up evaluations are also essential.